000 | 01259 a2200361 4500 | ||
---|---|---|---|
005 | 20250514193652.0 | ||
264 | 0 | _c20040928 | |
008 | 200409s 0 0 eng d | ||
022 | _a0004-8380 | ||
024 | 7 |
_a10.1111/j.1440-0960.2004.00091.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aO'Brien, Timothy J | |
245 | 0 | 0 |
_aAcral dysesthesia and trastuzumab (Herceptin). _h[electronic resource] |
260 |
_bThe Australasian journal of dermatology _cAug 2004 |
||
300 |
_a195-6 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aEdema _xchemically induced |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFoot |
650 | 0 | 4 | _aHand |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aParesthesia _xchemically induced |
650 | 0 | 4 | _aSyndrome |
650 | 0 | 4 | _aTrastuzumab |
773 | 0 |
_tThe Australasian journal of dermatology _gvol. 45 _gno. 3 _gp. 195-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1440-0960.2004.00091.x _zAvailable from publisher's website |
999 |
_c14953910 _d14953910 |